(E)-3-[[[[6-(2-CARBOXYETHENYL)-5-[[8-(4-METHOXYPHENYL)OCTYL]OXY]-2-PYRIDINYL]-METHYL]THIO]METHYL]BENZOIC ACID - A NOVEL HIGH-AFFINITY LEUKOTRIENE-B(4) RECEPTOR ANTAGONIST

被引：11
|
作者：
DAINES, RA [1 ]
CHAMBERS, PA [1 ]
PENDRAK, I [1 ]
JAKAS, DR [1 ]
SARAU, HM [1 ]
FOLEY, JJ [1 ]
SCHMIDT, DB [1 ]
GRISWOLD, DE [1 ]
MARTIN, LD [1 ]
KINGSBURY, WD [1 ]
机构：
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT PHARMACOL,KING OF PRUSSIA,PA 19406
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1993年 / 36卷 / 18期
关键词：
D O I：
10.1021/jm00070a015
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2703 / 2705
页数：3
相关论文
共 29 条
  • [21] SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5 methoxyindol-1-yl]-1-[2′methyl-4′-(5-methyl-1,2,3-oxadiazol-3-yl) biphenyl-4-yl]methanone hydrochloride):: A novel, potent and selective 5-HT1B receptor antagonist
    Scott, Claire
    Langmead, Christopher J.
    Clarke, Kirsten L.
    Wyman, Paul
    Smith, Paul W.
    Starr, Kathryn R.
    Dawson, Lee A.
    Price, Gary W.
    Hagan, James J.
    Watson, Jeannette
    NEUROPHARMACOLOGY, 2006, 50 (08) : 984 - 990
  • [22] Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein
    Yu, Qingzhen
    Kumata, Katsushi
    Collier, Thomas
    Tomita, Susumu
    Zhang, Ming-Rong
    Liang, Steven
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S97 - S98
  • [23] Characterization of tritiated JNJ-GluN2B-5 (3-[3H] 1-(azetidin-1-yl)-2-(6-(4-fluoro-3-methyl-phenyl)pyrrolo[3,2-b]pyridin-1-yl)ethanone), a high affinity GluN2B radioligand with selectivity over sigma receptors
    Schoellerman, Jeffrey
    Lord, Brian
    Bhattacharya, Anindya
    Stenne, Brice
    Wall, Jessica L.
    Rech, Jason
    Letavic, Michael
    Bonaventure, Pascal
    Balana, Bartosz
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (09) : 2654 - 2670
  • [24] Pharmacological Characterization of (3S)-3-(Hydroxymethyl)-4-(5-Methylpyridin-2-yl)-N-[6-(2,2,2-Trifluoroethoxy)pyridin-3-yl]-3,4-Dihydro-2H-Benzo[b][1,4]Oxazine-8-Carboxamide (JTS-653), a Novel Transient Receptor Potential Vanilloid 1 Antagonist
    Kitagawa, Yoshihiro
    Miyai, Atsuko
    Usui, Kenji
    Hamada, Yuji
    Deai, Katsuya
    Wada, Masashi
    Koga, Yoshihisa
    Sakata, Masahiro
    Hayashi, Mikio
    Tominaga, Makoto
    Matsushita, Mutsuyoshi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (02): : 520 - 528
  • [25] Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisonne Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume (vol 52, pg 3846, 2009)
    Acton, John J.
    Akiyama, Taro E.
    Chang, Ching H.
    Colwell, Lawrence
    Debenham, Sheryl
    Doebber, Thomas
    Einstein, Monica
    Liu, Kun
    McCann, Margaret E.
    Moller, David E.
    Muise, Eric S.
    Tan, Yejun
    Thompson, John R.
    Wong, Kenny K.
    Wu, Margaret
    Xu, Libo
    Meinke, Peter T.
    Berger, Joel P.
    Wood, Harold B.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) : 9368 - 9368
  • [26] Radiosynthesis of 6-(2-cyclobutyl-5-[11C]methyl-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one as a novel PET tracer for imaging of γ-8 dependent transmembrane PA receptor regulatory protein
    Yu, Qingzhen
    Chen, Zhen
    Kumata, Katsushi
    Shao, Tuo
    Wey, Hsiao-Ying
    Shao, Yihan
    Josephson, Lee
    Zhang, Ming-Rong
    Liang, Steven
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [27] 5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide:: A [11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans
    Rabiner, EA
    Wilkins, MR
    Turkheimer, F
    Gunn, RN
    De Haes, JU
    De Vries, M
    Grasby, PM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03): : 1144 - 1150
  • [28] Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist
    De Savi, Chris
    Bradbury, Robert H.
    Rabow, Alfred A.
    Norman, Richard A.
    de Almeida, Camila
    Andrews, David M.
    Ballard, Peter
    Buttar, David
    Callis, Rowena J.
    Currie, Gordon S.
    Curwen, Jon O.
    Davies, Chris D.
    Donald, Craig S.
    Feron, Lyman J. L.
    Gingell, Helen
    Glossop, Steven C.
    Hayter, Barry R.
    Hussain, Syeed
    Karoutchi, Galith
    Lamont, Scott G.
    MacFaul, Philip
    Moss, Thomas A.
    Pearson, Stuart E.
    Tonge, Michael
    Walker, Graeme E.
    Weir, Hazel M.
    Wilson, Zena
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (20) : 8128 - 8140
  • [29] DETERMINATION OF (+)-5-(2,3-DIHYDROBENZOFURAN-7-YL)-3-METHYL-8-NITRO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-7-OL(NNC01-0687), A NOVEL DOPAMINE D-1 RECEPTOR ANTAGONIST, IN PLASMA BY SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    CHRISTENSEN, JV
    JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 577 (02): : 366 - 370
123